Thomas S. Templeman
Net worth: 2 M $ as of 2024-06-29
Profile
Thomas S.
Templeman held various senior positions in pharmaceutical and biotech companies such as Centocor, Hospira, Liquidia Technologies, Graybug Vision, Ortho-Clinical Diagnostics, Gene Trak Systems, Vysis Sarl, Medivation, Sio Gene Therapies, Axovant Sciences, Nuvation Bio, and Centessa Pharmaceuticals Plc.
He worked as a General Manager, VP-Manufacturing Science & Technology, Senior Vice President-Integrated Supply Chain, Chief Operating Officer, Program Manager-Process Engineering, Project Leader, Operations Manager, and Senior VP-Pharmaceutical Operations & Quality.
Templeman earned a doctorate degree from Dartmouth College and an undergraduate degree from Santa Clara University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-30 | 188,244 ( 0.21% ) | 2 M $ | 2024-06-29 |
Former positions of Thomas S. Templeman
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 2023-02-28 |
| NUVATION BIO INC. | Corporate Officer/Principal | 2021-04-30 |
| SIO GENE THERAPIES INC. | Corporate Officer/Principal | 2018-01-31 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Corporate Officer/Principal | 2018-01-31 |
| CALCIMEDICA, INC. | Chief Operating Officer | 2017-05-31 |
Training of Thomas S. Templeman
| Santa Clara University | Undergraduate Degree |
| Dartmouth College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NUVATION BIO INC. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Private companies | 10 |
|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Gene Trak Systems
 Gene Trak Systems Medical SpecialtiesHealth Technology Part of Neogen Corp., Gene Trak Systems is an American company that provides food testing services using innovative DNA probe-based products for bacterial contaminants. Gene Trak Systems was acquired by Neogen Corp. from Abbott Molecular, Inc. on August 06, 2001 for $3.50 million. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Vysis Sarl
 Vysis Sarl Medical DistributorsDistribution Services Part of Applied Genetic Services Ltd., Vysis Sarl is a French company that distributes pharmaceutical products. Vysis was acquired by Applied Genetic Services Ltd. from Abbott Molecular, Inc. on February 08, 2000 for $1.27 million. | Distribution Services |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Thomas S. Templeman
